Contacts

MedinCell receives 7,5 M€ from the European Bank of Investment (EIB)

July 23, 2019

• Payment of the second tranche of 7.5 M€ in line with expectations
• Strengthened financial visibility of the Company
• 5 M€ drawable under conditions from the EIB loan


The EIB lent MedinCell with 20 M€ in three tranches. The first was paid in March 2018. The conditions for the second one of 7.5 M€ were met. The third tranche of 5.0 M€ is still available under conditions.

Strengthened financial visibility
As a reminder, MedinCell had as of March 31, 2019:
• 21.3 M€ in cash and cash equivalents + 0.7 M€ in short-term investments
• 3.9 M€ in non-current financial assets
To which are added:
• 7,5 M€ from the second tranche received today
• 5 M€ drawable under conditions from the EIB loan
• revenues from existing partnerships and the Research Tax Credit
These amounts are to be put into perspective with the cash consumption related to the activity which as a reminder was 15.9 M€ for the 2018/2019 financial year.

Session en français

Mardi 19 décembre, 18h30 : Présentation des résultats du premier semestre de l'année fiscale 2023-24

English session

Tuesday, December 19, 6:30 pm: Half-year earnings call (April 1st - September 30th)

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.

CONTACT

  • This field is for validation purposes and should be left unchanged.